drugset / Trial / NCT00647933
An Open-label, Single Center Trial to Assess the Pharmacokinetics, Pharmacodynamics and Safety of Org 36286 (P07004)
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The objectives of this study were to study the pharmacokinetics, pharmacodynamics and safety of Org 36286 after a single subcutaneous administration in healthy females.
Timeline
- Start
- 2000-06
- Primary completion
- 2000-12
- Completion
- 2000-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Corifollitropin alfa | Protein / enzyme biologic | 15 ug | Subcutaneous |
| Subject | Corifollitropin alfa | Protein / enzyme biologic | 30 ug | Subcutaneous |
| Subject | Corifollitropin alfa | Protein / enzyme biologic | 60 ug | Subcutaneous |
| Subject | Corifollitropin alfa | Protein / enzyme biologic | 120 ug | Subcutaneous |
| Background | Lynestrenol | Small molecule | 2.5 mg | Oral |
| Background | ethinyl estradiol | Small molecule | 50 ug | Oral |